Reuters logo
BRIEF-Cellular Biomedicine had working capital of $38.3 mln as of Dec. 31
March 14, 2017 / 10:22 AM / 6 months ago

BRIEF-Cellular Biomedicine had working capital of $38.3 mln as of Dec. 31

March 14 (Reuters) - Cellular Biomedicine Group Inc

* Cellular biomedicine group reports full-year 2016 financial results and recent operational progress

* Cellular biomedicine group inc- had working capital of $38.3 million as of december 31, 2016 compared to $13.7 million as of december 31, 2015 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below